Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
Andrew J. Kesner, David M. Lovinger
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1674-1696
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Advancing biological investigations using portable sensors for detection of sensitive samples
Tahir ul Gani Mir, Atif Khurshid Wani, Nahid Akhtar, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22679-e22679
Open Access | Times Cited: 17
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 7
Chronic pain, chronic stress and substance use: overlapping mechanisms and implications
Jay Schaffer, Nia Fogelman, Dae Yun Seo, et al.
Frontiers in Pain Research (2023) Vol. 4
Open Access | Times Cited: 13
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study: L’arrêt de l’utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l’étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques
Brian Bond, Bea Duric, Edoardo Spinazzola, et al.
The Canadian Journal of Psychiatry (2025)
Closed Access
Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis
Iasmina-Alexandra Predescu, Alex-Robert Jîjie, Dalia Pătrașcu, et al.
Pharmacy (2025) Vol. 13, Iss. 1, pp. 7-7
Open Access
Epidemiology and Health Impacts of Substance Use
Richard Alecsander Reichert, Flávia Zacouteguy Boos, Fernanda Machado Lopes, et al.
(2025), pp. 87-119
Closed Access
Higher prevalence of pulmonary tuberculosis revealed by Xpert MTB/RIF ultra among drug users in Kinshasa, Democratic Republic of Congo
Guillaume Bandjondo Nkisi, Doudou Malekita Yobi, Bive Zono, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Analytical and medico‐legal problems linked to the presence of delta‐8‐tetrahydrocannabinol (delta‐8‐THC): Results from urine drug testing in Sweden
Anders Helander, Malin Johansson, Annika Andersson, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 2, pp. 371-376
Open Access | Times Cited: 24
THC, CBD, and Anxiety: a Review of Recent Findings on the Anxiolytic and Anxiogenic Effects of Cannabis’ Primary Cannabinoids
Sarah Lichenstein
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 473-485
Open Access | Times Cited: 16
Changes in striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence in male and female mice
Andrew J. Kesner, Yolanda Mateo, Karina Possa Abrahao, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 8, pp. 1537-1549
Open Access | Times Cited: 14
Endocannabinoid-Binding Receptors as Drug Targets
María Gómez‐Cañas, Carmen Rodríguez‐Cueto, Valentina Satta, et al.
Methods in molecular biology (2022), pp. 67-94
Closed Access | Times Cited: 14
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol
Elisa Landucci, Costanza Mazzantini, Daniele Lana, et al.
Toxics (2022) Vol. 10, Iss. 2, pp. 48-48
Open Access | Times Cited: 12
Edible marijuana products and potential risks for pediatric populations
Allison Lin, Mary J. O’Connor, Reta Behnam, et al.
Current Opinion in Pediatrics (2022) Vol. 34, Iss. 3, pp. 279-287
Closed Access | Times Cited: 12
Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212–2
Abigail L. Brewer, Claire E. Felter, Anna R. Sternitzky, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 236, pp. 173707-173707
Closed Access | Times Cited: 2
Attenuation of cannabis withdrawal symptoms by Prosopis farcta extract, its luteolin and melatonin in mice: Involvement of brain‐derived neurotrophic factor and dopamine
Javad Ghasemian‐Yadegari, Ahmad Adineh, Hamidreza Mohammadi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 2
Altered sleep during spontaneous cannabinoid withdrawal in male mice
Galen Missig, Niyati Mehta, James O. Robbins, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 2&3, pp. 195-205
Open Access | Times Cited: 10
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence
Nicolás Lamanna‐Rama, Karina S. MacDowell, Glenda M. Torres Lopez, et al.
European Neuropsychopharmacology (2023) Vol. 69, pp. 60-76
Open Access | Times Cited: 6
Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials
Caroline Vuilleumier, Norbert Scherbaum, Udo Bonnet, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 9
Sleep disturbance after cessation of cannabis administration in mice
Takashi Asano, Hiroki Takemoto, Tomoya Horita, et al.
Neuropsychopharmacology Reports (2023) Vol. 43, Iss. 4, pp. 505-512
Open Access | Times Cited: 4
Is it time for a cannabis harm reduction approach? Commentary on Sherman et al. (2022) and Borodovsky et al. (2022).
Bryant M. Stone, Brian J. Sherman
Psychology of Addictive Behaviors (2023) Vol. 37, Iss. 5, pp. 709-712
Open Access | Times Cited: 4
Cannabis significantly alters DNA methylation of the human ovarian follicle in a concentration-dependent manner
Noga Fuchs Weizman, Brandon A. Wyse, Janice Montbriand, et al.
Molecular Human Reproduction (2022) Vol. 28, Iss. 7
Open Access | Times Cited: 6
Is Mindfulness Associated With Safer Cannabis Use? A Latent Profile Analysis of Dispositional Mindfulness Among College Students Who Use Cannabis
Hannah A. Carlon, Jennifer Earnest, Margo C. Hurlocker
Mindfulness (2023) Vol. 14, Iss. 4, pp. 797-807
Closed Access | Times Cited: 3
Deletion of Cryab increases the vulnerability of mice to the addiction-like effects of the cannabinoid JWH-018 via upregulation of striatal NF-κB expression
Leandro Val Sayson, Darlene Mae Ortiz, Hyun Jun Lee, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective
Luke J. Ney, Wọlé Akóṣílè, Christopher G. Davey, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1093-1108
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top